510(k) Report

510(k) · Cleared

Cleared

Elecsys SHBG Immunoassay

K031717510(k) TraditionalCleared Aug 5, 200363-day reviewClass I21 CFR 862.1680

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Roche Diagnostics Corp. · CDZ Radioimmunoassay, Testosterones And Dihydrotestosterone

Cleared on Aug 5, 2003 as substantially equivalent to K941797 (Diagnostic Products Corp., 1994) after a 63-day review. Its family tree reaches back 1 generation to 1994. 4 later devices descend from it.

Decided
Aug 5, 2003
Review
63 days
Class
Class I
Product code
CDZ
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K941797 (1994). 4 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2007: 1 descendant cleared2011: 1 descendant cleared2016: 1 descendant cleared2015: 1 descendant clearedK941797 · Immulite SHBG · Diagnostic Products Corp. · 19941990200020102020
Descendants, by generation 1 generation forward: 2 descendants2 generations forward: 2 descendants K941797 · Immulite SHBG · Diagnostic Products Corp. · 19940
  1. Root · 1 generation backK941797 Immulite SHBGDiagnostic Products Corp. · 1994
  2. This deviceK031717 Elecsys SHBG ImmunoassayRoche Diagnostics Corp. · 2003
  3. Descendant · cites it directly · 2 of its ownK060818 Architect SHBG Reagent Kit, Architect SHBG Calibrator Kit, and…Biokit, S.A. · 2007 · Recalled
  4. Descendant · 2 generations on · 0 of its ownK152185 Architect SHBGBiokit, S.A. · 2016
  5. Descendant · 2 generations on · 0 of its ownK143075 ST AIA-PACK SHBG, ST AIA-PACK SHBG Calibrator SetTosoh Bioscience, Inc. · 2015 · Recalled
  6. Descendant · cites it directly · 0 of its ownK102814 Elecysys SHBGRoche Diagnostics · 2011

Most influential descendants

Showing 4 of 4 · See all
  • K060818Architect SHBG Reagent Kit, Architect SHBG Calibrator Kit, and Architect SHBG Control…Biokit, S.A. · 2007 · cites it directly2descendants
  • K152185Architect SHBGBiokit, S.A. · 2016 · 2 generations on0descendants
  • K143075ST AIA-PACK SHBG, ST AIA-PACK SHBG Calibrator SetTosoh Bioscience, Inc. · 2015 · 2 generations on0descendants
  • K102814Elecysys SHBGRoche Diagnostics · 2011 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K941797Immulite SHBGDiagnostic Products Corp.1994—
0 (this device)K031717Elecsys SHBG ImmunoassayRoche Diagnostics Corp.2003—
+1K060818Architect SHBG Reagent Kit, Architect SHBG Calibrator Kit, and Architect SHBG…Biokit, S.A.20071
+2K152185Architect SHBGBiokit, S.A.2016—
+2K143075ST AIA-PACK SHBG, ST AIA-PACK SHBG Calibrator SetTosoh Bioscience, Inc.20151
+1K102814Elecysys SHBGRoche Diagnostics2011—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200710
201110
201510
201610
FIG. 1 — Lineage of K031717, 1994–2016Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CDZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CDZ device

  1. #1 K252728 IDS-iSYS Total Testosteronescore 11.8 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K941797Immulite SHBG
Summary page 3
…ally equivalent to other devices equivalence legally marketed in the United States. We claim equivalence to the DPC Immulite SHBG cleared under K941797. Both products are intended for use in the quantitative determination of sex hormone binding globulin. Subst…
Diagnostic Products Corp.1994—

Also cleared against K941797: 1 other device →

What descends from it? (4)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K060818Architect SHBG Reagent Kit, Architect SHBG Calibrator Kit, and Architect SHBG Control…Biokit, S.A.20072
K102814Elecysys SHBGRoche Diagnostics20110

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K060818 (Biokit, S.A., 2007) has gone furthest, with 2 descendants of its own.
  • 1 other device also cites its predicate K941797.

How does its category compare?

All CDZ devices

CDZ Radioimmunoassay, Testosterones And Dihydrotestosterone: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · CDZ

2in 2024

2007: 12009: 12010: 22011: 22012: 12013: 12014: 12015: 22016: 42018: 12019: 42020: 12022: 12023: 12024: 22026 (partial year): 1
2007high 4 (2016) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CDZ

141in 2019

2016: 276 days median2019: 141 days median
2007high 276 (2016) · low 141 (2019)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · CDZ

1in 2025

2010: 12013: 12018: 12022: 12024: 12025: 12026 (partial year): 1
2007high 1 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · CDZ

17in 2025

2007: 62008: 32009: 12010: 12011: 192012: 92013: 72014: 102015: 72016: 52017: 122018: 52019: 32020: 122021: 72022: 32023: 102024: 112025: 17
2007high 19 (2011) · low 1 (2009)2025

MAUDE reports naming product code CDZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—06
20080—03
20091—01
20102—11
20112—019
20121—09
20131—17
20141—010
20152—07
2016427605
20170—012
20181—15
2019414103
20201—012
20210—07
20221—13
20231—010
20242—111
20250—117
20261—1—

What is it indicated for?

Immunoassay for the in vitro quantitative determination sex hormone binding globulin in human serum and plasma. The Elecsys SHBG Immunoassay is intended for use as an aid in the diagnosis of androgen disorders including hirsuitism, virilization, polycystic ovarian syndrome, adrenogenital syndrome, and hyperandrogenism; the correct interpretation of testosterone and estradiol concentrations; investigation of the androgen-estrogen balance in gonadal and sexual dysfunction; assessment of the peripheral effect of hormones which regulate SHBG concentrations. The electrochemiluminescence immunoassay "ECLIA" is intended for use on the Roche Elecsys family of analyzers.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K031717: Elecsys SHBG Immunoassay.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K031717

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026